Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra Dudareva

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Journal of Hepatology|February 25, 2024
Comment on "Population-based screening works: Effect of integrating screening for hepatitis B and C into the general health check-up in Germany"Renke Biallas, Ruth Zimmermann, Sandra Dudareva
Journal of the International AIDS Society|July 26, 2024
Eliminating perinatal transmission of hepatitis B virus: it is time for actionRania A Tohme, Su Wang, Benjamin Cowie, et al.
Frontiers in Public Health|April 22, 2025
Estimated number of people infected with hepatitis B and C virus in Germany in 2013: a baseline prevalence estimate using the workbook methodKatrin Kremer-Flach, Ruth Zimmermann, Matthias An der Heiden, et al.
BMC Infectious Diseases|January 16, 2026
Adherence to hepatitis B vaccination recommendations for children and adolescents aged 3 to 17 years in Germany, 2014-2017: results from a cross-sectional national population-based studySofie Gillesberg Lassen, Thomas Harder, Sandra Dudareva, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|July 26, 2017
[Sexually transmitted infections in Germany : The current epidemiological situation]Viviane Bremer, Sandra Dudareva-Vizule, Susanne Buder, et al.
Sexually Transmitted Infections|August 8, 2013
Prevalence of pharyngeal and rectal Chlamydia trachomatis and Neisseria gonorrhoeae infections among men who have sex with men in GermanySandra Dudareva-Vizule, Karin Haar, Andrea Sailer, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|December 16, 2020
[How to assess the elimination of viral hepatitis B, C, and D in Germany? Outcomes of an interdisciplinary workshop]Ruth Zimmermann, Wiebe Külper-Schiek, Gyde Steffen, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|August 26, 2020
[How well is the screening of pregnant women for HIV, syphilis, and hepatitis B implemented in Germany? An analysis based on routine data]Sandra Beermann, Josephine Jacob, Sandra Dudareva, et al.
Frontiers in Public Health|June 16, 2023
Additional challenges in reaching hepatitis C elimination goals in Germany due to the COVID-19 pandemic - descriptive analysis of drug prescription data from January 2018 to June 2021Emily D Meyer, Sandra Dudareva, Christian Kollan, et al.
BMC Infectious Diseases|August 27, 2018
Not again! Effect of previous test results, age group and reason for testing on (re-)infection with Chlamydia trachomatis in GermanyAlexandra Sarah Lang, Matthias An der Heiden, Klaus Jansen, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Journal of Hepatology|February 25, 2024
Comment on "Population-based screening works: Effect of integrating screening for hepatitis B and C into the general health check-up in Germany"Renke Biallas, Ruth Zimmermann, Sandra Dudareva
Journal of the International AIDS Society|July 26, 2024
Eliminating perinatal transmission of hepatitis B virus: it is time for actionRania A Tohme, Su Wang, Benjamin Cowie, et al.
Frontiers in Public Health|April 22, 2025
Estimated number of people infected with hepatitis B and C virus in Germany in 2013: a baseline prevalence estimate using the workbook methodKatrin Kremer-Flach, Ruth Zimmermann, Matthias An der Heiden, et al.
BMC Infectious Diseases|January 16, 2026
Adherence to hepatitis B vaccination recommendations for children and adolescents aged 3 to 17 years in Germany, 2014-2017: results from a cross-sectional national population-based studySofie Gillesberg Lassen, Thomas Harder, Sandra Dudareva, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|July 26, 2017
[Sexually transmitted infections in Germany : The current epidemiological situation]Viviane Bremer, Sandra Dudareva-Vizule, Susanne Buder, et al.
Sexually Transmitted Infections|August 8, 2013
Prevalence of pharyngeal and rectal Chlamydia trachomatis and Neisseria gonorrhoeae infections among men who have sex with men in GermanySandra Dudareva-Vizule, Karin Haar, Andrea Sailer, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|December 16, 2020
[How to assess the elimination of viral hepatitis B, C, and D in Germany? Outcomes of an interdisciplinary workshop]Ruth Zimmermann, Wiebe Külper-Schiek, Gyde Steffen, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|August 26, 2020
[How well is the screening of pregnant women for HIV, syphilis, and hepatitis B implemented in Germany? An analysis based on routine data]Sandra Beermann, Josephine Jacob, Sandra Dudareva, et al.
Frontiers in Public Health|June 16, 2023
Additional challenges in reaching hepatitis C elimination goals in Germany due to the COVID-19 pandemic - descriptive analysis of drug prescription data from January 2018 to June 2021Emily D Meyer, Sandra Dudareva, Christian Kollan, et al.
BMC Infectious Diseases|August 27, 2018
Not again! Effect of previous test results, age group and reason for testing on (re-)infection with Chlamydia trachomatis in GermanyAlexandra Sarah Lang, Matthias An der Heiden, Klaus Jansen, et al.
Pageof 5